InsiderTrades

Form 4 for SLDB Solid Biosciences Inc.

Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-13 · accession 0000950170-25-022199 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DTI 2025-02-18 2025-02-13 SLDB Ganot Ilan Dir M - OptEx — +4,861 16.6K +42% —
DTI 2025-02-18 2025-02-14 SLDB Ganot Ilan Dir S - Sale+OE $3.96 -1,711 14.8K -10% -$6,776
DTI 2025-02-18 2025-02-13 SLDB Ganot Ilan Dir M - OptEx $0.00 -4,861 14.6K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-13 M A 4,861 — 16,550 I Wife — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
2 Common Common Stock 2025-02-14 S D 1,711 $3.96 14,839 I Wife — — (F3) This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot.
3 Derivative Restricted Stock Units 2025-02-13 M D 4,861 $0.00 14,583 I Wife — · — to — 4,861 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F5) On February 13, 2024 (the "Grant Date") Ms. Ganot was granted 19,444 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.